Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis

O Axelrod1, S Klaus, S Frankenburg

  • 1Department of Dermatology, Hadassah Medical Organization, Jerusalem, Israel.

Parasite Immunology
|November 1, 1994
PubMed

Insights

Epidermal Langerhans cells (LC) can present Leishmania antigens early in infection, but are not infected, suggesting they don't initiate cutaneous leishmaniasis. This impacts understanding early immune responses to parasitic skin infections.

Area of Science:

  • Immunology
  • Parasitology
  • Dermatology

Background:

  • Cutaneous leishmaniasis is a parasitic skin disease.
  • Early immune responses in the skin are crucial for disease outcome.
  • Leishmania parasites infect skin cells upon intradermal injection.

Purpose of the Study:

  • To investigate the role of epidermal Langerhans cells (LC) in the early immune response to Leishmania major infection.
  • To determine if LC can be infected in vivo and function as antigen-presenting cells (APCs) during the initial hours of infection.
  • To assess the specificity of LC antigen presentation.

Main Methods:

  • In vivo infection of mice with Leishmania major.
  • Isolation of epidermal Langerhans cells (LC) at various time points post-infection.
  • Assessment of LC antigen-presenting capacity using leishmania-specific and ovalbumin-specific T cell lines.
  • Microscopic examination for parasite presence in the epidermis.

Main Results:

  • Epidermal Langerhans cells (LC) presented Leishmania antigens to a specific T cell line as early as 4 hours post-infection.
  • LC from infected mice did not present ovalbumin, and LC from ovalbumin-injected mice did not present Leishmania antigens, confirming specificity.
  • No Leishmania parasites were detected within the epidermis, despite LC's antigen-presenting ability.

Conclusions:

  • Epidermal Langerhans cells (LC) are capable of presenting Leishmania antigens early in the infection process.
  • LC do not appear to be directly involved in establishing the initial parasitic infection in the epidermis.
  • These findings highlight the role of LC in initiating adaptive immunity to cutaneous leishmaniasis without being the primary site of infection.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...